An integrated multi-omics approach reveals polymethoxylated flavonoid biosynthesis in Citrus reticulata cv. Chachiensis

Citrus reticulata cv. Chachiensis (CRC) is an important medicinal plant, its dried mature peels named “Guangchenpi”, has been used as a traditional Chinese medicine to treat cough, indigestion, and lung diseases for several hundred years. However, the biosynthesis of the crucial natural products pol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature communications 2024-05, Vol.15 (1), p.3991-19, Article 3991
Hauptverfasser: Wen, Jiawen, Wang, Yayu, Lu, Xu, Pan, Huimin, Jin, Dian, Wen, Jialing, Jin, Canzhi, Sahu, Sunil Kumar, Su, Jianmu, Luo, Xinyue, Jin, Xiaohuan, Zhao, Jiao, Wu, Hong, Liu, E-Hu, Liu, Huan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Citrus reticulata cv. Chachiensis (CRC) is an important medicinal plant, its dried mature peels named “Guangchenpi”, has been used as a traditional Chinese medicine to treat cough, indigestion, and lung diseases for several hundred years. However, the biosynthesis of the crucial natural products polymethoxylated flavonoids (PMFs) in CRC remains unclear. Here, we report a chromosome-scale genome assembly of CRC with the size of 314.96 Mb and a contig N50 of 16.22 Mb. Using multi-omics resources, we discover a putative caffeic acid O -methyltransferase (CcOMT1) that can transfer a methyl group to the 3-hydroxyl of natsudaidain to form 3,5,6,7,8,3’,4’-heptamethoxyflavone (HPMF). Based on transient overexpression and virus-induced gene silencing experiments, we propose that CcOMT1 is a candidate enzyme in HPMF biosynthesis. In addition, a potential gene regulatory network associated with PMF biosynthesis is identified. This study provides insights into PMF biosynthesis and may assist future research on mining genes for the biosynthesis of plant-based medicines. Citrus reticulata cv. Chachiensis (CRC) is used in traditional Chinese medicine to treat various ailments. Here Wen et al . provide genomic, transcriptomic and metabolomic resources for CRC and propose a possible biosynthetic pathway for bioactive components.
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-024-48235-y